Research on ereythropoietin and its receptor in anemia of neoplasm
10.3760/cma.j.issn.1009-9921.2008.03.026
- VernacularTitle:促红细胞生成素及其受体与肿瘤性贫血的研究
- Author:
Mei FENG
;
Muya MA
- Publication Type:Journal Article
- Keywords:
Erythropoietin;
Erythmpoietin,recombinant;
Anemia
- From:
Journal of Leukemia & Lymphoma
2008;17(3):231-233
- CountryChina
- Language:Chinese
-
Abstract:
The anemia of chronic disease is chronic infection, inflammation, a class of cancer-related anemia syndrome, anemia in patients with malignant tumors often. In recent years recombinant human erythropoietin, widely used in clinical treatment of anemia, Especially in cancer-related anemia treatment achieved remarkable results, a blood transfusion to avoid the many adverse effects and improve the patient' s quality of life. A control chemotherapy-induced anemia is an important choice. Therefore, rhEPO on cancer-related anemia treatment mechanism has also become a research hotspot.
